It differs from a report examining AML generated on a Trpm2-/- genetic background in murine hematopoietic cells induced by retroviral introduction of MLL-AF9 or BCR-ABL-GFP and NUP98-HOXA9-YFP41. The gene discussed is ABL1; the disease is acute myeloid leukemia.